215 related articles for article (PubMed ID: 12150662)
1. Nesiritide vs nitroglycerin for decompensated congestive heart failure.
Rifkin W
JAMA; 2002 Aug; 288(5):572; author reply 572-3. PubMed ID: 12150662
[No Abstract] [Full Text] [Related]
2. Nesiritide vs nitroglycerin for decompensated congestive heart failure.
Dunavant S
JAMA; 2002 Aug; 288(5):571-2; author reply 572-3. PubMed ID: 12150661
[No Abstract] [Full Text] [Related]
3. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial.
Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF)
JAMA; 2002 Mar; 287(12):1531-40. PubMed ID: 11911755
[TBL] [Abstract][Full Text] [Related]
4. B-type natriuretic peptide: from bench to bedside.
Adams KF; Mathur VS; Gheorghiade M
Am Heart J; 2003 Feb; 145(2 Suppl):S34-46. PubMed ID: 12594450
[No Abstract] [Full Text] [Related]
5. The failing heart and the hemodynamic response to vasodilator therapy.
Mills RM
Clin Cardiol; 2003 Jun; 26(6):257-8. PubMed ID: 12839041
[No Abstract] [Full Text] [Related]
6. Clinical and hemodynamic effects of nesiritide (B-type natriuretic peptide) in patients with decompensated heart failure receiving beta blockers.
Abraham WT; Cheng ML; Smoluk G;
Congest Heart Fail; 2005; 11(2):59-64. PubMed ID: 15860969
[TBL] [Abstract][Full Text] [Related]
7. Nesiritide - not verified.
Topol EJ
N Engl J Med; 2005 Jul; 353(2):113-6. PubMed ID: 16014879
[No Abstract] [Full Text] [Related]
8. Beneficial effects of early initiation of vasoactive agents in patients with acute decompensated heart failure.
Saltzberg MT
Rev Cardiovasc Med; 2004; 5 Suppl 4():S17-27. PubMed ID: 15627915
[TBL] [Abstract][Full Text] [Related]
9. Comparison of effects on left ventricular filling pressure of intravenous nesiritide and high-dose nitroglycerin in patients with decompensated heart failure.
Elkayam U; Akhter MW; Singh H; Khan S; Usman A
Am J Cardiol; 2004 Jan; 93(2):237-40. PubMed ID: 14715359
[TBL] [Abstract][Full Text] [Related]
10. Nesiritide: a review of its use in acute decompensated heart failure.
Keating GM; Goa KL
Drugs; 2003; 63(1):47-70. PubMed ID: 12487622
[TBL] [Abstract][Full Text] [Related]
11. Risk of death with nesiritide.
Burger AJ
JAMA; 2005 Aug; 294(8):897; author reply 898. PubMed ID: 16118377
[No Abstract] [Full Text] [Related]
12. Critical review and recommendations for nesiritide use in the emergency department.
Collins SP; Hinckley WR; Storrow AB
J Emerg Med; 2005 Oct; 29(3):317-29. PubMed ID: 16183453
[TBL] [Abstract][Full Text] [Related]
13. Nesiritide: the latest drug for treating heart failure.
Fontana D
Crit Care Nurse; 2006 Feb; 26(1):39-44, 46-7. PubMed ID: 16443809
[No Abstract] [Full Text] [Related]
14. Nesiritide (Natrecor): a new treatment for acutely decompensated congestive heart failure.
Colbert K; Greene MH
Crit Care Nurs Q; 2003; 26(1):40-4. PubMed ID: 12669946
[TBL] [Abstract][Full Text] [Related]
15. Nesiritide for the treatment of congestive heart failure.
Iyengar S; Feldman DS; Trupp R; Abraham WT
Expert Opin Pharmacother; 2004 Apr; 5(4):901-7. PubMed ID: 15102572
[TBL] [Abstract][Full Text] [Related]
16. Vasodilator therapy for decompensated heart failure.
Yancy CW
J Am Coll Cardiol; 2008 Jul; 52(3):208-10. PubMed ID: 18617069
[No Abstract] [Full Text] [Related]
17. The use of vasoactive therapy for acute decompensated heart failure: hemodynamic and renal considerations.
Heywood JT; Khan TA
Rev Cardiovasc Med; 2007; 8 Suppl 5():S22-9. PubMed ID: 18192950
[TBL] [Abstract][Full Text] [Related]
18. Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study.
Burger AJ; Horton DP; LeJemtel T; Ghali JK; Torre G; Dennish G; Koren M; Dinerman J; Silver M; Cheng ML; Elkayam U;
Am Heart J; 2002 Dec; 144(6):1102-8. PubMed ID: 12486437
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic stabilization and management of acute heart failure syndromes in the emergency department.
Kirk JD; Parissis JT; Filippatos G
Heart Fail Clin; 2009 Jan; 5(1):43-54, vi. PubMed ID: 19026385
[TBL] [Abstract][Full Text] [Related]
20. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group.
Colucci WS; Elkayam U; Horton DP; Abraham WT; Bourge RC; Johnson AD; Wagoner LE; Givertz MM; Liang CS; Neibaur M; Haught WH; LeJemtel TH
N Engl J Med; 2000 Jul; 343(4):246-53. PubMed ID: 10911006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
